APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI-Assisted Drug Discovery Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI-Assisted Drug Discovery Software Market Outlook and Growth Opportunities 2026

5 June 2026196 pages

Choose your research edition.

Industry ResearchAI-Assisted Drug Discovery Software Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal AI-Assisted Drug Discovery Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal AI-Assisted Drug Discovery Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI-Assisted Drug Discovery Software Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI-Assisted Drug Discovery Software Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

The global AI-Assisted Drug Discovery Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI-Assisted Drug Discovery Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI-Assisted Drug Discovery Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI-Assisted Drug Discovery Software market include AIDDISON, Atomwise Inc, BenevolentAI, BullFrog AI, Cyclica, Exscientia, Genesis Therapeutics Inc, Insilico Medicine and Recursion Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI-Assisted Drug Discovery Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI-Assisted Drug Discovery Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI-Assisted Drug Discovery Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI-Assisted Drug Discovery Software market.

AI-Assisted Drug Discovery Software Segment by Company

AIDDISON

Atomwise Inc

BenevolentAI

BullFrog AI

Cyclica

Exscientia

Genesis Therapeutics Inc

Insilico Medicine

Recursion Pharmaceuticals

Verge Genomics

AI-Assisted Drug Discovery Software Segment by Type

On Premise Software

Cloud-Based Software

AI-Assisted Drug Discovery Software Segment by Application

Biopharmaceuticals

Pharmaceuticals

Others

AI-Assisted Drug Discovery Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI-Assisted Drug Discovery Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI-Assisted Drug Discovery Software key companies, revenue, market share, and recent developments.

3. To split the AI-Assisted Drug Discovery Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI-Assisted Drug Discovery Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI-Assisted Drug Discovery Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI-Assisted Drug Discovery Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-Assisted Drug Discovery Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI-Assisted Drug Discovery Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-Assisted Drug Discovery Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI-Assisted Drug Discovery Software industry.

Chapter 3: Detailed analysis of AI-Assisted Drug Discovery Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI-Assisted Drug Discovery Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI-Assisted Drug Discovery Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI-Assisted Drug Discovery Software Industry Trends Table 2. AI-Assisted Drug Discovery Software Industry Drivers Table 3. AI-Assisted Drug Discovery Software Industry Opportunities and Challenges Table 4. AI-Assisted Drug Discovery Software Industry Restraints Table 5. Global AI-Assisted Drug Discovery Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI-Assisted Drug Discovery Software Revenue Share by Company (2021-2026) Table 7. Global AI-Assisted Drug Discovery Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI-Assisted Drug Discovery Software Key Company Manufacturing Base & Headquarters Table 9. Global AI-Assisted Drug Discovery Software Company, Product Type & Application Table 10. Global AI-Assisted Drug Discovery Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI-Assisted Drug Discovery Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On Premise Software Table 15. Significant Companies of Cloud-Based Software Table 16. Global AI-Assisted Drug Discovery Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI-Assisted Drug Discovery Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI-Assisted Drug Discovery Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI-Assisted Drug Discovery Software Sales Value Share by Type (2021-2026) Table 20. Global AI-Assisted Drug Discovery Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Biopharmaceuticals Table 22. Significant Companies of Pharmaceuticals Table 23. Significant Companies of Others Table 24. Global AI-Assisted Drug Discovery Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global AI-Assisted Drug Discovery Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global AI-Assisted Drug Discovery Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global AI-Assisted Drug Discovery Software Sales Value Share by Application (2021-2026) Table 28. Global AI-Assisted Drug Discovery Software Sales Value Share by Application (2027-2032) Table 29. Global AI-Assisted Drug Discovery Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global AI-Assisted Drug Discovery Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global AI-Assisted Drug Discovery Software Sales Value Share by Region (2021-2026) Table 32. Global AI-Assisted Drug Discovery Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global AI-Assisted Drug Discovery Software Sales Value Share by Region (2027-2032) Table 34. Global AI-Assisted Drug Discovery Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global AI-Assisted Drug Discovery Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global AI-Assisted Drug Discovery Software Sales Value Market Share by Country (2021-2026) Table 37. Global AI-Assisted Drug Discovery Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global AI-Assisted Drug Discovery Software Sales Value Market Share by Country (2027-2032) Table 39. AIDDISON Company Information Table 40. AIDDISON Business Overview Table 41. AIDDISON AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. AIDDISON AI-Assisted Drug Discovery Software Product Portfolio Table 43. AIDDISON Recent Development Table 44. Atomwise Inc Company Information Table 45. Atomwise Inc Business Overview Table 46. Atomwise Inc AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio Table 48. Atomwise Inc Recent Development Table 49. BenevolentAI Company Information Table 50. BenevolentAI Business Overview Table 51. BenevolentAI AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio Table 53. BenevolentAI Recent Development Table 54. BullFrog AI Company Information Table 55. BullFrog AI Business Overview Table 56. BullFrog AI AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio Table 58. BullFrog AI Recent Development Table 59. Cyclica Company Information Table 60. Cyclica Business Overview Table 61. Cyclica AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Cyclica AI-Assisted Drug Discovery Software Product Portfolio Table 63. Cyclica Recent Development Table 64. Exscientia Company Information Table 65. Exscientia Business Overview Table 66. Exscientia AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Exscientia AI-Assisted Drug Discovery Software Product Portfolio Table 68. Exscientia Recent Development Table 69. Genesis Therapeutics Inc Company Information Table 70. Genesis Therapeutics Inc Business Overview Table 71. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio Table 73. Genesis Therapeutics Inc Recent Development Table 74. Insilico Medicine Company Information Table 75. Insilico Medicine Business Overview Table 76. Insilico Medicine AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio Table 78. Insilico Medicine Recent Development Table 79. Recursion Pharmaceuticals Company Information Table 80. Recursion Pharmaceuticals Business Overview Table 81. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio Table 83. Recursion Pharmaceuticals Recent Development Table 84. Verge Genomics Company Information Table 85. Verge Genomics Business Overview Table 86. Verge Genomics AI-Assisted Drug Discovery Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio Table 88. Verge Genomics Recent Development Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. AI-Assisted Drug Discovery Software Product Image Figure 2. Global AI-Assisted Drug Discovery Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI-Assisted Drug Discovery Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI-Assisted Drug Discovery Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On Premise Software Image Figure 8. Cloud-Based Software Image Figure 9. Global AI-Assisted Drug Discovery Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI-Assisted Drug Discovery Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI-Assisted Drug Discovery Software Sales Value Share by Type (2021-2032) Figure 12. Biopharmaceuticals Image Figure 13. Pharmaceuticals Image Figure 14. Others Image Figure 15. Global AI-Assisted Drug Discovery Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global AI-Assisted Drug Discovery Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global AI-Assisted Drug Discovery Software Sales Value Share by Application (2021-2032) Figure 18. Global AI-Assisted Drug Discovery Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global AI-Assisted Drug Discovery Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America AI-Assisted Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America AI-Assisted Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe AI-Assisted Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe AI-Assisted Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific AI-Assisted Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific AI-Assisted Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America AI-Assisted Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America AI-Assisted Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa AI-Assisted Drug Discovery Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa AI-Assisted Drug Discovery Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • On Premise Software
  • Cloud-Based Software
Applications
  • Biopharmaceuticals
  • Pharmaceuticals
  • Others
Companies covered
  • AIDDISON
  • Atomwise Inc
  • BenevolentAI
  • BullFrog AI
  • Cyclica
  • Exscientia
  • Genesis Therapeutics Inc
  • Insilico Medicine
  • Recursion Pharmaceuticals
  • Verge Genomics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI-Assisted Drug Discovery Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI-Assisted Drug Discovery Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI-Assisted Drug Discovery Software Market Dynamics
  1. 2.1 AI-Assisted Drug Discovery Software Industry Trends
  2. 2.2 AI-Assisted Drug Discovery Software Industry Drivers
  3. 2.3 AI-Assisted Drug Discovery Software Industry Opportunities and Challenges
  4. 2.4 AI-Assisted Drug Discovery Software Industry Restraints
3 AI-Assisted Drug Discovery Software Market by Company
  1. 3.1 Global AI-Assisted Drug Discovery Software Company Revenue Ranking in 2025
  2. 3.2 Global AI-Assisted Drug Discovery Software Revenue by Company (2021-2026)
  3. 3.3 Global AI-Assisted Drug Discovery Software Company Ranking (2024-2026)
  4. 3.4 Global AI-Assisted Drug Discovery Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI-Assisted Drug Discovery Software Company Product Type and Application
  6. 3.6 Global AI-Assisted Drug Discovery Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI-Assisted Drug Discovery Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI-Assisted Drug Discovery Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI-Assisted Drug Discovery Software Market by Type
  1. 4.1 AI-Assisted Drug Discovery Software Type Introduction
  2. 4.1.1 On Premise Software
  3. 4.1.2 Cloud-Based Software
  4. 4.2 Global AI-Assisted Drug Discovery Software Sales Value by Type
  5. 4.2.1 Global AI-Assisted Drug Discovery Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI-Assisted Drug Discovery Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI-Assisted Drug Discovery Software Sales Value Share by Type (2021-2032)
5 AI-Assisted Drug Discovery Software Market by Application
  1. 5.1 AI-Assisted Drug Discovery Software Application Introduction
  2. 5.1.1 Biopharmaceuticals
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Others
  5. 5.2 Global AI-Assisted Drug Discovery Software Sales Value by Application
  6. 5.2.1 Global AI-Assisted Drug Discovery Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global AI-Assisted Drug Discovery Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global AI-Assisted Drug Discovery Software Sales Value Share by Application (2021-2032)
6 AI-Assisted Drug Discovery Software Regional Value Analysis
  1. 6.1 Global AI-Assisted Drug Discovery Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI-Assisted Drug Discovery Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI-Assisted Drug Discovery Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI-Assisted Drug Discovery Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI-Assisted Drug Discovery Software Sales Value (2021-2032)
  7. 6.3.2 North America AI-Assisted Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI-Assisted Drug Discovery Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI-Assisted Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI-Assisted Drug Discovery Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI-Assisted Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI-Assisted Drug Discovery Software Sales Value (2021-2032)
  16. 6.6.2 South America AI-Assisted Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI-Assisted Drug Discovery Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI-Assisted Drug Discovery Software Sales Value Share by Country, 2025 VS 2032
7 AI-Assisted Drug Discovery Software Country-level Value Analysis
  1. 7.1 Global AI-Assisted Drug Discovery Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI-Assisted Drug Discovery Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI-Assisted Drug Discovery Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI-Assisted Drug Discovery Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI-Assisted Drug Discovery Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI-Assisted Drug Discovery Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI-Assisted Drug Discovery Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AIDDISON
  2. 8.1.1 AIDDISON Company Information
  3. 8.1.2 AIDDISON Business Overview
  4. 8.1.3 AIDDISON AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AIDDISON AI-Assisted Drug Discovery Software Product Portfolio
  6. 8.1.5 AIDDISON Recent Developments
  7. 8.2 Atomwise Inc
  8. 8.2.1 Atomwise Inc Company Information
  9. 8.2.2 Atomwise Inc Business Overview
  10. 8.2.3 Atomwise Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Atomwise Inc AI-Assisted Drug Discovery Software Product Portfolio
  12. 8.2.5 Atomwise Inc Recent Developments
  13. 8.3 BenevolentAI
  14. 8.3.1 BenevolentAI Company Information
  15. 8.3.2 BenevolentAI Business Overview
  16. 8.3.3 BenevolentAI AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BenevolentAI AI-Assisted Drug Discovery Software Product Portfolio
  18. 8.3.5 BenevolentAI Recent Developments
  19. 8.4 BullFrog AI
  20. 8.4.1 BullFrog AI Company Information
  21. 8.4.2 BullFrog AI Business Overview
  22. 8.4.3 BullFrog AI AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BullFrog AI AI-Assisted Drug Discovery Software Product Portfolio
  24. 8.4.5 BullFrog AI Recent Developments
  25. 8.5 Cyclica
  26. 8.5.1 Cyclica Company Information
  27. 8.5.2 Cyclica Business Overview
  28. 8.5.3 Cyclica AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cyclica AI-Assisted Drug Discovery Software Product Portfolio
  30. 8.5.5 Cyclica Recent Developments
  31. 8.6 Exscientia
  32. 8.6.1 Exscientia Company Information
  33. 8.6.2 Exscientia Business Overview
  34. 8.6.3 Exscientia AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Exscientia AI-Assisted Drug Discovery Software Product Portfolio
  36. 8.6.5 Exscientia Recent Developments
  37. 8.7 Genesis Therapeutics Inc
  38. 8.7.1 Genesis Therapeutics Inc Company Information
  39. 8.7.2 Genesis Therapeutics Inc Business Overview
  40. 8.7.3 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Genesis Therapeutics Inc AI-Assisted Drug Discovery Software Product Portfolio
  42. 8.7.5 Genesis Therapeutics Inc Recent Developments
  43. 8.8 Insilico Medicine
  44. 8.8.1 Insilico Medicine Company Information
  45. 8.8.2 Insilico Medicine Business Overview
  46. 8.8.3 Insilico Medicine AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Insilico Medicine AI-Assisted Drug Discovery Software Product Portfolio
  48. 8.8.5 Insilico Medicine Recent Developments
  49. 8.9 Recursion Pharmaceuticals
  50. 8.9.1 Recursion Pharmaceuticals Company Information
  51. 8.9.2 Recursion Pharmaceuticals Business Overview
  52. 8.9.3 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Recursion Pharmaceuticals AI-Assisted Drug Discovery Software Product Portfolio
  54. 8.9.5 Recursion Pharmaceuticals Recent Developments
  55. 8.10 Verge Genomics
  56. 8.10.1 Verge Genomics Company Information
  57. 8.10.2 Verge Genomics Business Overview
  58. 8.10.3 Verge Genomics AI-Assisted Drug Discovery Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Verge Genomics AI-Assisted Drug Discovery Software Product Portfolio
  60. 8.10.5 Verge Genomics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst